Summit Therapeutics PLC logo

Summit Therapeutics PLC

LSE:SUMM (USA)  
£ 0.21 (0%) Feb 21
At Loss
P/B:
31.45
Market Cap:
£ 68.91M ($ 87.98M)
Enterprise V:
£ -287.03M ($ -366.46M)
Volume:
-
Avg Vol (2M):
-
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
-

Summit Therapeutics PLC Valuation Measures